Paloma Partners Management CO Global Blood Therapeutics, Inc. Transaction History

Paloma Partners Management CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$24.9 - $40.26 $398,748 - $644,723	-16,014 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$25.48 - $37.34 $408,036 - $597,962	16,014 New	16,014 $408,000
Q1 2021 May 17, 2021	SELL	$38.94 - $50.85 $603,570 - $788,175	-15,500 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$37.65 - $63.77 $1.39 Million - $2.36 Million	-36,978 Reduced 70.46%	15,500 $671,000
Q3 2020 Nov 16, 2020	SELL	$52.76 - $74.49 $867,954 - $1.23 Million	-16,451 Reduced 23.87%	52,478 $2.89 Million
Q2 2020 Aug 14, 2020	BUY	$48.73 - $81.82 $3.36 Million - $5.64 Million	68,929 New	68,929 $4.35 Million

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

Stay updated on Paloma Partners Management CO with notifications on news.